Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation

Fig. 2

Changes in galectin-3 levels following LVAD implantation. a Galectin-3 levels show a trend towards lower levels early after LVAD placement at 3 and 6 months but were higher in patients at the time of LVAD explanation (**p < 0.01). b Dynamics of 14 paired patient samples time of implantation to time of explantation

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us